In the lead-up to US Thanksgiving 2025, several Irish start-ups have made significant strides in establishing their presence in the American market. These companies are leading the charge in various sectors, showing adaptability and innovation as they expand their reach across the pond. Swoop, based in New York, recently garnered a strategic investment of $6 million from Sandbox Industries, specializing in insurance, healthcare, and sustainability, to boost the production of custom products for retailers. This expansion is powered by a vast network of over 30,000 manufacturers across the US, Canada, Ireland, and the UK. Protex AI, founded in Limerick, has developed a computer vision-powered platform for warehouses that autonomously captures unsafe events through their CCTV devices. The recognition of Protex AI’s efforts came when it was awarded Outstanding Achievement in International Growth at the Technology Ireland Ibec Industry Awards. This acknowledgment highlights the growing importance of technology and safety in the workplace, especially as they make inroads into the US market. Moving forward, Deciphex, a medical technology company from Dublin, announced that it raised €15 million in venture debt funding from Claret Capital Partners. This funding is aimed at accelerating its expansion into the US, reflecting the growing demand for innovative medtech solutions in the healthcare sector. Their recent recognition as a finalist in the Irish Medtech Awards for Medtech Company of the Year indicates their commitment to healthcare innovation, which is critical as they broaden their market footprint. Nory, also based in Dublin and London, has raised $37 million in a Series B funding round aimed at improving efficiency in business intelligence, inventory management, workforce management, and payroll for the restaurant industry. Their services can reportedly save restaurant owners significant administrative time, allowing them to focus on core business activities. Meanwhile, ProVerum, co-founded by Dr. Ríona Ní Ghriallais and Dr. Conor Harkin, raised $80 million in a Series B financing round. Their initial focus is on investigative use in the US market, reflecting a strategy that concentrates on building a solid foundation before broadening their product availability. Overall, these bold moves signify a growing trend of Irish start-ups thriving in a competitive American marketplace, highlighting innovation and strategic investment as key drivers of their success.